13.58 million people prioritize Chen Shizhong vaccine: target to reach 60% coverage in the third quarter of next year-Wufei Vaccine No Competition Health Network



[ad_1]

The Health Minister and Fu Chen Shizhong emphasized that it is not that he personally chose not to manufacture vaccines in China, but that he was not allowed to import vaccines. Also, vaccines from China have had problems in the past and the quality of Chinese vaccines doubts. (Photo by reporter Fang Bin)

[Reporter Lin Huiqin / Taipei Report]Health and Welfare Minister Chen Shizhong went to the Legislative Yuan Sanitation and Social Welfare Committee to report on the business of the Ministry of Health and Welfare today. Many lawmakers are concerned about the development of the Wuhan pneumonia (novel coronavirus disease, COVID-19) vaccine. Chen Shizhong mentioned that many people are concerned that there will be a second wave of epidemics in autumn and winter, but in fact, there is already a second wave in summer, and Taiwan does not have it. The vaccine is expected to reach 60% of the population, and the goal is the third quarter of next year.

Regarding the progress of the vaccine, Chen Shizhong pointed out that there are currently 156 contracting countries in the global procurement mechanism for COVAX Wuhan pneumonia vaccine. He frankly admits that the vaccination schedule is difficult, but there should be routine vaccinations in the second quarter of next year. The market is expected to become a buyer in the middle of next year. The market will also dynamically assess and schedule the order and timing of the attack based on domestic and foreign epidemics.

Regarding the order of priority for pneumonia vaccination in Wuhan, the Disease Management Agency of the Ministry of Health and Welfare discussed at an expert consultation meeting in July. The priority of vaccination is medical personnel, epidemic prevention personnel, police and military police, personnel of long-term care institutions, military personnel, 65 years old. The aforementioned elderly, those aged 19 to 64 with high-risk diseases that can easily lead to serious illness, rare diseases and serious injuries, and adults aged 50 to 64, number 13.58 million and cover 60% of the total population.

DPP lawmaker Gao Jiayu asked in a question at the Social Welfare and Sanitation Committee today when will the so-called priority ethnic group of 60% of the total population be vaccinated? Chen Shizhong pointed out that many people are concerned that there will be a second wave in autumn and winter, but in fact there is already a second wave in summer, and Taiwan does not have it. The vaccine is expected to reach 60% of the population. Under the premise that everything is going well, the goal can be reached in the third quarter of next year. This coverage rate.

Kuomintang lawmaker Wu Sihuai was concerned that the government would declare that it would not buy the Wuhan pneumonia vaccine made in China, but currently COVAX has a Chinese vaccine. If the quality of the Chinese vaccine is certified by then, the center Command should consider people’s rights and review and evaluate them. DPP lawmaker Zhuang Jingcheng noted that people are concerned about the influx of Chinese vaccines into Taiwan.

Chen Shizhong stressed that it was not that he personally chose not to make vaccines in China, but that he was not allowed to import vaccines. Also, there have been problems with Chinese vaccines in the past and he still has doubts about the quality of Chinese vaccines.

The Legislative Yuan Committee on Social Welfare and Sanitation and Environmental Protection met on the 28th and invited the Minister of Health and Welfare Chen Shizhong to report on the business outlook and prepare questions. (Photo by reporter Fang Bin)

☆ Health news is not lost, follow the fan page by likes.

☆ For more important medical news, visit FreeHealth.com.

No need to draw, no need to take the news now, use the app to watch the news and make sure you win every day. I download the app and follow me to see the activity method.



[ad_2]